Content » Vol 73, Issue 2

Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis.

DOI: 10.2340/0001555573141142


Eight patients with severe atopic dermatitis were treated with interferon-alpha (IFN-alpha 2b), given by subcutaneous injection, three times a week. The maximum doses varied from 3 to 9 x 10(6) U and the period of treatment from 6 to 14 weeks. The therapy was well tolerated. No changes were observed in eczema or IgE levels, although IFN-alpha 2b treatment significantly decreased blood eosinophils.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.